Kenjiro Akai
Tohoku University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kenjiro Akai.
Circulation Research | 1992
Hiroshi Kanatsuka; Nobuyo Sekiguchi; Kouichi Sato; Kenjiro Akai; Yan Wang; Tatsuya Komaru; Kouichi Ashikawa; Tamotsu Takishima
Our aim was to elucidate the site and mechanism responsible for reactive hyperemia in coronary circulation. In in vivo beating canine hearts, microvessels of the left anterior descending coronary artery (LAD) were observed through a microscope equipped with a floating objective. Flow velocity of the LAD was measured with a suction-type Doppler probe. The LAD was occluded for 20 or 30 seconds and then released, and reactive hyperemia was observed before and after 8-phenyltheophylline (7.5 mg/kg i.v.) or glibenclamide (200 micrograms/kg into the LAD) infusion. During the occlusion, only arterial microvessels smaller than 100 microns in diameter dilated. Dilation of those vessels was partially attenuated by 8-phenyltheophylline and completely abolished with glibenclamide. In the early phase of reactive hyperemia, all arterial microvessels dilated, and the magnitude of peak dilation was greater in vessels smaller than 100 microns compared with those larger than 100 microns. Vasodilation during reactive hyperemia ceased within 60 seconds in vessels smaller than 100 microns but was sustained for more than 120 seconds in those larger than 100 microns. 8-Phenyltheophylline did not change peak dilation of arterial microvessels but reduced dilation after the peak. Glibenclamide remarkably attenuated dilation of all arterial microvessels in the whole phase of reactive hyperemia. These results indicate that all arterial microvessels are responsible for reactive hyperemia after coronary artery occlusions of 20-30 seconds, but there is greater participation of vessels smaller than 100 microns in the early phase of reactive hyperemia. Dilation of vessels larger than 100 microns assumes an important role in the later phase. ATP-sensitive K+ channels mediate dilation of arterial microvessels both in brief ischemia and reactive hyperemia.
Journal of Cardiovascular Pharmacology | 1995
Kenjiro Akai; Yan Wang; Kouichi Sato; Nobuyo Sekiguchi; Akihiko Sugimura; Toshinobu Kumagai; Tatsuya Komaru; Hiroshi Kanatsuka; Kunio Shirato
We aimed to clarify the size dependency of nicorandil-induced dilation in coronary microcirculation and the involvement of adenosine triphosphate (ATP)-sensitive potassium channels. Coronary arterial microvessels were observed through a microscope equipped with a floating objective in anesthetized open-chest dogs (n = 29). Heart rate and mean aortic pressure were maintained at control level. In 16 dogs, nicorandil was infused into the coronary in a cumulative fashion (0.1, 1.0, 10, and 100 micrograms/kg/min, for 5 min for each dose). In 13 dogs, glibenclamide (10 microM) was topically applied onto the observed area, and nicorandil was similarly infused. Nicorandil dilated vessels < 100 microns in diameter at all applied doses in a dose-dependent manner. Glibenclamide abolished the dilation of these vessels at the lower two doses. Vessels > 100 microns in diameter dilated only at the two higher doses and the dilation was not affected by glibenclamide. These data suggest that the vessels < 100 microns are more sensitive to this agent than other size vessels, and that ATP-sensitive potassium channels are involved in the nicorandil-induced dilation of vessels smaller than 100 microns, whereas the dilation of other size vessels occurs independently of this channel.
Circulation Research | 1994
Tatsuya Komaru; Yan Wang; Kenjiro Akai; Kouichi Sato; Nobuyo Sekiguchi; Akihiko Sugimura; Toshinobu Kumagai; Hiroshi Kanatsuka; Kunio Shirato
GTP-binding regulatory proteins (G proteins) regulate various biological functions, but their participation in controlling coronary microvascular tone has not been established yet. The goal of the present study was to elucidate the role of pertussis toxin (PTX)-sensitive G protein in regulating coronary microvascular tone during autoregulation and ischemia. In 42 open-chest dogs, coronary arterial microvessels on the surface of the left ventricle were directly observed by epi-illuminated fluorescence microangiography using a floating objective system. PTX (300 ng/mL) was superfused onto the surface of the left ventricle for 2 hours to block Gi and G(o) protein in epimyocardial coronary microvessels in vivo. PTX superfusion caused no change in the resting diameters of microvessels and significantly blocked the vasoconstriction induced by BHT 920 (a selective alpha 2-agonist). After pretreatment with PTX or its vehicle, the left anterior descending coronary artery (LAD) was occluded by a hydraulic occluder to reduce coronary perfusion pressure (CPP) in a stepwise fashion. A mild stenosis (CPP, 60 mm Hg), a severe stenosis (CPP, 40 mm Hg), and complete occlusion were sequentially produced. Coronary flow velocity in the LAD distal to the stenotic site was continuously monitored. In both PTX and vehicle groups, flow velocity did not significantly decrease during mild stenosis, proving that transmural coronary autoregulatory function was well preserved in the preparation. During severe stenosis and complete occlusion, the coronary flow velocity significantly decreased. In the vehicle group, microvessels < 100 microns in inner diameter significantly dilated in response to the reduction in perfusion pressure (mild stenosis, 6.2 +/- 1.9%; severe stenosis, 21.1 +/- 4.4%; and complete occlusion, 16.8 +/- 5.9%; P < .05 versus baseline diameters). In the PTX group, microvessels did not dilate during each occlusion level (mild stenosis, -2.0 +/- 0.9%; severe stenosis, -3.9 +/- 1.9%; and complete occlusion, -13.4 +/- 2.9%; P < .05 versus vehicle group). PTX did not affect the microvascular dilation caused by nitroprusside. The present data indicate that PTX-sensitive G protein is crucially involved in microvascular control during autoregulation and ischemia.
Journal of the American College of Cardiology | 1996
Tatsuya Komaru; Shogen Isoyama; Nobuyo Sekiguchi; Kenjiro Akai; Nobuyuki Shiba; Satoshi Yasuda; Masayuki Funakoshi; Kunio Shirato; Masayuki Zuguchi; Eiji Nozaki; Osamu Nishioka; Kenji Tamaki
OBJECTIVES This study sought to investigate the effect of coronary angioplasty on chronic hypoperfusion-induced endothelial dysfunction in patients with coronary heart disease. BACKGROUND The endothelium is an important component for organ flow regulation. Ischemia with or without reperfusion is known to cause endothelial dysfunction. We tested the hypothesis that chronic hypoperfusion impairs endothelial function in the angiographically normal coronary artery segment distal to stenosis and that the impairment by chronic hypoperfusion is reduced by coronary angioplasty. METHODS In 13 patients with stable angina pectoris, substance P (10, 30 and 100 pmol) and nitroglycerin (200 micrograms) were sequentially infused into the coronary artery in a cumulative manner on the day after coronary angioplasty. In 10 of these patients, vascular responses to these agents were again investigated 3 months after angioplasty. Changes in vascular diameter were evaluated in vessels located proximal and distal to the target lesion, both of which were angiographically normal, by performing computer-assisted quantitative coronary angiography. In five patients, the transstenotic pressure gradient was also measured with a pressure sensor-mounted guide wire before angioplasty. RESULTS On the day after angioplasty, the magnitude of dilation by substance P in distal segments was significantly less than that in proximal segments and inversely correlated with the transstenotic pressure gradient (p < 0.05) and lesion stenosis (p < 0.05). There was no difference in nitroglycerin-induced vasodilation between the two vessel segment groups. Three months later, the impaired response to substance P in the distal segment was restored to normal. CONCLUSIONS We conclude that chronic hypoperfusion impairs endothelium-dependent dilation of coronary artery distal to critical stenosis in patients with ischemic heart disease and that coronary angioplasty ameliorates the endothelial dysfunction within 3 months.
Heart and Vessels | 1997
Tsutomu Watanabe; Shogen Isoyama; Akihiro Nakamura; Kunio Shirato; Hironobu Kubota; Nobuyo Sekiguchi; Fumitoshi Sato; Atsushi Katoh; Kei Munakata; Masafumi Sugi; Eiji Nozaki; Osamu Nishioka; Kenji Tamaki; Kenjiro Akai; Takao Araki; Koichi Yokoyama
SummaryTo test the hypothesis that antiatherogenicity in women exerts beneficial effects to prevent restenosis formation after coronary angioplasty, we studied 493 men (988 lesions) and 81 women (159 lesions), aged 40–60 years, who had undergone successful balloon angioplasty and had follow-up angiography, 4.9±4.1 months later. We compared the extent of restenosis between men and women, and between pre- and post-menopausal women, which was assessed by a categorical definition of restenosis (more than 50% diameter stenosis at follow-up) and by percent diameter measured immediately after angioplasty and at follow-up. Hypertension was more frequent in women and a significantly lower percentage of women smoked. In women, the levels of total cholesterol and low-density lipoprotein cholesterol were higher. The location of dilated lesions, frequency of angioplasty for lesions with chronic total occlusion, and frequency of emergency angioplasty in patients with unstable angina or acute myocardial infarction were similar in men and women. Restenosis formation, estimated by the categorical definition or percent diameter, did not differ between men and women, or between pre- and post-menopausal women. Menopausal status or sex was not an independent predictor of restenosis by multivariate analysis. Thus, the benefit of anti-atherogenicity in women does not play an important role in preventing restenosis after coronary angioplasty.
Cardiovascular Research | 1994
Kouichi Sato; Hiroshi Kanatsuka; Nobuyo Sekiguchi; Kenjiro Akai; Yan Wang; Akihiko Sugimura; Toshinobu Kumagai; Tatsuya Komaru; Kunio Shirato
Japanese Circulation Journal-english Edition | 1999
Yan Wang; Hiroshi Kanatsuka; Kenjiro Akai; Akihiko Sugimura; Toshinobu Kumagai; Tatsuya Komaru; Kouichi Sato; Kunio Shirato
Cardiovascular Research | 1992
Nobuyo Sekiguchi; Hiroshi Kanatsuka; Tatsuya Komaru; Kenjiro Akai; Kouichi Sato; Yan Wang; Masafumi Sugi; Kouichi Ashikawa; Tamotsu Takishima
Japanese Circulation Journal-english Edition | 2002
Kazutaka Aonuma; Yasuteru Yamauchi; Hitoshi Hachiya; Hiroyuki Okada; Atsushi Suzuki; Takaaki Haga; Akira Satoh; Mihoe Inada; Masayoshi Korenaga; Akihiko Nogami; Yoshito Iesaka; Mitsuaki Isobe; Junichi Nitta; Kenichiro Ohtomo; Tetsuya Asakawa; Sunao Mochizuki; Kenjiro Akai
The Japanese Society of Intensive Care Medicine | 1999
Tomoyasu Yahagi; Gen-ya Yaginuma; Takao Araki; Toshikazu Goto; Sukehiko Kawashima; Kenjiro Akai; Takamichi Miyamoto; Koichi Yokoyama